date:Dec 29, 2012
aboration with Nestle. Having knowledge of the complete S. salivarius K12 genome significantly contributes to our understanding of the role of this species in the microbial ecology of the mouth and throat and its beneficial role on human health.
Dr. Barry Richardson, CEO of BLIS Technologies states, the completion of the BLIS K12 genome sequence is a significant milestone in the commercial development of the BLIS K12 probiotic and once again confirms the excellent safety of the organism.
Und